Lyell Immunopharma
Lyell Immunopharma, Inc., a clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. ...
Lyell Immunopharma Logo
About Lyell Immunopharma
Lyell Immunopharma, Inc. operates as a cellular therapy company. The Company develops curative cell-based immunotherapies for patients with solid tumors and hematologic malignancies. Lyell Immunopharma serves customers worldwide.
Address
201 Haskins Way,
South San Francisco, 94080
United States
Year founded
2018
Number of employees
300
